BioCentury
ARTICLE | Clinical News

Celtrix data

May 10, 1993 7:00 AM UTC

All the patients had macular hole damage of less than one year duration. They were treated surgically by vitrectomy. The treatment groups received either a low dose of 660 nanograms of BetaKine or the high dose around the edges of the hole during the procedure. ...